0
0
Read Time:12 Second
NEW DELHI: The Indian Council of Medical Research (ICMR) and Panacea Biotec announced on Wednesday that they have started the first-ever Phase 3 clinical trial for its anti-dengue vaccine candidate in India; the country currently does not have an…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %